teferrol and Celiac-Disease

The rate of infusion reactions to total-dose intravenous iron polymaltose is very low, but the frequency and severity of adverse reactions following the infusion are unknown. In 50 consecutive patients, adverse reactions developed up to 2 days after the infusion in 26% and lasted 1-8 days (median 4). Severe systemic reactions occurred in 8%. Patients should be warned of the chance of delayed reactions and an alternative iron preparation should be considered if parenteral iron is again indicated.

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthralgia; Celiac Disease; Female; Ferric Compounds; Fever; Gastrointestinal Diseases; Headache; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Malabsorption Syndromes; Male; Middle Aged; Stomach Diseases; Young Adult